Proov
Kristine Quine is an experienced financial advisor at Edward Jones, where a commitment to long-term investing philosophy guides client relationships. As the founder and principal consultant of Wayfinder Growth Consulting, Kristine aids organizations in achieving transformative growth through integrated strategy and change management. In their role as Chief Operating Officer at MFB Fertility, Kristine contributes to the success of the innovative Proov test, empowering women in reproductive health. Previous experience includes leadership positions at Flytedesk and XO Communications, where Kristine drove significant growth and reduced employee turnover. Additionally, Kristine served as adjunct faculty at the University of Denver's Daniels College of Business, focusing on business development in MBA programs. Kristine co-founded Smart-Girl, Inc., promoting leadership in young women, and holds an MBA from the University of Denver.
This person is not in any teams
This person is not in any offices
Proov
2 followers
Proov offers a suite of in vitro diagnostics to provide fertility insights throughout the entire menstrual cycle. When paired with the free Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.